Connecting copper and cancer: from transition metal signalling to metalloplasia

[1]  P. Pandolfi,et al.  Copper Promotes Tumorigenesis by Activating the PDK1‐AKT Oncogenic Pathway in a Copper Transporter 1 Dependent Manner , 2021, Advanced science.

[2]  F. Giorgi,et al.  Copper: An Intracellular Achilles’ Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics , 2021, ChemMedChem.

[3]  A. Casini,et al.  Therapeutic potential of a copper complex loaded in pH-sensitive long circulating liposomes for colon cancer management. , 2021, International journal of pharmaceutics.

[4]  Vishal M. Gohil.  Repurposing elesclomol, an investigational drug for the treatment of copper metabolism disorders , 2020, Expert opinion on investigational drugs.

[5]  S. Gambhir,et al.  ED SUM: Triple-negative breast cancer is inhibited by depleting mitochondrial copper in mice. , 2020, Nature Biotechnology.

[6]  S. Moore,et al.  Getting out what you put in: copper in mitochondria and its impacts on human disease. , 2020, Biochimica et biophysica acta. Molecular cell research.

[7]  P. Cassier,et al.  Autophagy as a therapeutic target in pancreatic cancer , 2020, British Journal of Cancer.

[8]  J. Trapani,et al.  Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion , 2020, Cancer Research.

[9]  Philippe P Roux,et al.  Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer , 2020, Nature Communications.

[10]  Evan W. Miller,et al.  Activity-Based Sensing with a Metal-Directed Acyl Imidazole Strategy Reveals Cell Type-Dependent Pools of Labile Brain Copper. , 2020, Journal of the American Chemical Society.

[11]  G. Weisman,et al.  Metallothioneins regulate ATP7A trafficking and control cell viability during copper deficiency and excess , 2020, Scientific Reports.

[12]  S. Mitragotri,et al.  Targeting Strategies for Tissue-Specific Drug Delivery , 2020, Cell.

[13]  H. Adly,et al.  Serum Levels of Selenium, Zinc, Copper, Manganese, and Iron in Prostate Cancer Patients , 2020, Current Urology.

[14]  C. Coarfa,et al.  Metabolic dysregulation in the Atp7b−/− Wilson’s disease mouse model , 2020, Proceedings of the National Academy of Sciences.

[15]  Christopher J. Chang,et al.  Activity-Based Sensing: A Synthetic Methods Approach for Selective Molecular Imaging and Beyond. , 2020, Angewandte Chemie.

[16]  Guojun Wu,et al.  Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment. , 2019, Seminars in cancer biology.

[17]  D. Feldser,et al.  Copper is an essential regulator of the autophagic kinases ULK1/2 to drive lung adenocarcinoma , 2019, bioRxiv.

[18]  R. Schmid,et al.  New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness , 2019, Front. Oncol..

[19]  L. Rossi,et al.  Copper homeostasis as target of both consolidated and innovative strategies of anti-tumor therapy. , 2019, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[20]  C. Chung,et al.  Activity-based ratiometric FRET probe reveals oncogene-driven changes in labile copper pools induced by altered glutathione metabolism , 2019, Proceedings of the National Academy of Sciences.

[21]  K. Franz,et al.  Emerging Opportunities To Manipulate Metal Trafficking for Therapeutic Benefit. , 2019, Inorganic chemistry.

[22]  Christopher J. Chang,et al.  Inorganic Chemistry Approaches to Activity-Based Sensing: From Metal Sensors to Bioorthogonal Metal Chemistry. , 2019, Inorganic chemistry.

[23]  C. Fahrni,et al.  Ratiometric two-photon microscopy reveals attomolar copper buffering in normal and Menkes mutant cells , 2019, Proceedings of the National Academy of Sciences.

[24]  T. Golub,et al.  Mitochondrial metabolism promotes adaptation to proteotoxic stress , 2019, Nature Chemical Biology.

[25]  C. Chang,et al.  Copper (II) Ions Activate Ligand-Independent Receptor Tyrosine Kinase (RTK) Signaling Pathway , 2019, BioMed research international.

[26]  C. Slator,et al.  CHAPTER 4. Recent Advances in Anticancer Copper Compounds , 2019, Metal-based Anticancer Agents.

[27]  M. Schilsky,et al.  Clinical practice guidelines in Wilson disease. , 2019, Annals of translational medicine.

[28]  Shan Zhu,et al.  ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis , 2019, Proceedings of the National Academy of Sciences.

[29]  A. Casini,et al.  Copper complex nanoformulations featuring highly promising therapeutic potential in murine melanoma models. , 2019, Nanomedicine.

[30]  E. Petricoin,et al.  Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer , 2019, Nature Medicine.

[31]  O. Olopade,et al.  Inhibition of Copper Transport Induces Apoptosis in Triple-Negative Breast Cancer Cells and Suppresses Tumor Angiogenesis , 2019, Molecular Cancer Therapeutics.

[32]  G. Kroemer,et al.  Activation of Autophagy, Observed in Liver Tissues From Patients With Wilson Disease and From ATP7B-Deficient Animals, Protects Hepatocytes From Copper-Induced Apoptosis. , 2019, Gastroenterology.

[33]  Guojun Wu,et al.  Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBC , 2019, Scientific Reports.

[34]  J. Lopez,et al.  Copper Depletion as a Therapeutic Strategy in Cancer. , 2019, Metal ions in life sciences.

[35]  D. Thiele,et al.  X-ray structures of the high-affinity copper transporter Ctr1 , 2019, Nature Communications.

[36]  Marie C. Heffern,et al.  A Modular Ionophore Platform for Liver-Directed Copper Supplementation in Cells and Animals. , 2018, Journal of the American Chemical Society.

[37]  J. Kaplan,et al.  Copper-dependent amino oxidase 3 governs selection of metabolic fuels in adipocytes , 2018, PLoS biology.

[38]  C. Forest,et al.  Stabilization of Aliphatic Phosphines by Auxiliary Phosphine Sulfides Offers Zeptomolar Affinity and Unprecedented Selectivity for Probing Biological CuI. , 2018, Angewandte Chemie.

[39]  D. Pappin,et al.  DPM-1001 decreased copper levels and ameliorated deficits in a mouse model of Wilson's disease , 2018, Genes & development.

[40]  F. Paparo,et al.  64CuCl2 PET/CT in Prostate Cancer Relapse , 2018, The Journal of Nuclear Medicine.

[41]  Guojun Wu,et al.  Recent Advances in Antabuse (Disulfiram): The Importance of its Metal-binding Ability to its Anticancer Activity. , 2017, Current medicinal chemistry.

[42]  Gilles Gasser,et al.  A potent, selective, and orally bioavailable inhibitor of the protein-tyrosine phosphatase PTP1B improves insulin and leptin signaling in animal models , 2017, The Journal of Biological Chemistry.

[43]  C. Counter,et al.  Copper Chelation Inhibits BRAFV600E-Driven Melanomagenesis and Counters Resistance to BRAFV600E and MEK1/2 Inhibitors. , 2017, Cancer research.

[44]  Christopher J. Chang,et al.  Copper signaling in the brain and beyond , 2017, The Journal of Biological Chemistry.

[45]  V. Medici,et al.  Wilson disease: At the crossroads between genetics and epigenetics-A review of the evidence. , 2017, Liver research.

[46]  A. Tjønneland,et al.  Pre-diagnostic copper and zinc biomarkers and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort , 2017, Carcinogenesis.

[47]  S. Gamanagatti,et al.  Hepatocellular Carcinoma: An Unusual Complication of Longstanding Wilson Disease. , 2017, Journal of clinical and experimental hepatology.

[48]  O. Stål,et al.  Defining the human copper proteome and analysis of its expression variation in cancers. , 2017, Metallomics : integrated biometal science.

[49]  Cheri M Ackerman,et al.  Analytical Methods for Imaging Metals in Biology: From Transition Metal Metabolism to Transition Metal Signaling. , 2017, Analytical chemistry.

[50]  Marie C. Heffern,et al.  In vivo bioluminescence imaging reveals copper deficiency in a murine model of nonalcoholic fatty liver disease , 2016, Proceedings of the National Academy of Sciences.

[51]  Y. Jiao,et al.  Disulfiram's Anticancer Activity: Evidence and Mechanisms. , 2016, Anti-cancer agents in medicinal chemistry.

[52]  A. Willis,et al.  Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases , 2016, Clinical Cancer Research.

[53]  Rubel Chakravarty,et al.  64Cu2+ Ions as PET Probe: An Emerging Paradigm in Molecular Imaging of Cancer. , 2016, Molecular pharmaceutics.

[54]  Safacan Kolemen,et al.  Thioether Coordination Chemistry for Molecular Imaging of Copper in Biological Systems. , 2016, Israel journal of chemistry.

[55]  M. Linder,et al.  Ceruloplasmin and other copper binding components of blood plasma and their functions: an update. , 2016, Metallomics : integrated biometal science.

[56]  E. White,et al.  Recent insights into the function of autophagy in cancer , 2016, Genes & development.

[57]  S. Kaler.  ATP7A-Related Copper Transport Disorders , 2016 .

[58]  A. Duatti,et al.  Imaging of Brain Tumors with Copper-64 Chloride: Early Experience and Results. , 2016, Cancer biotherapy & radiopharmaceuticals.

[59]  D. Tran,et al.  A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy , 2016, Journal of Neuro-Oncology.

[60]  M. Siddique,et al.  PET Imaging of Copper Trafficking in a Mouse Model of Alzheimer Disease , 2016, The Journal of Nuclear Medicine.

[61]  F. Aksoy,et al.  Changes in the Serum Levels of Trace Elements Before and After the Operation in Thyroid Cancer Patients , 2016, Biological Trace Element Research.

[62]  Cheng Luo,et al.  Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferation. , 2015, Nature chemistry.

[63]  G. Rubini,et al.  Copper-64 Dichloride as Theranostic Agent for Glioblastoma Multiforme: A Preclinical Study , 2015, BioMed research international.

[64]  P. Liu,et al.  The cytotoxic mechanisms of disulfiram and copper(ii) in cancer cells , 2015, Toxicology research.

[65]  Martin D de Jonge,et al.  Imaging metals in biology: balancing sensitivity, selectivity and spatial resolution. , 2015, Chemical Society reviews.

[66]  Allegra T. Aron,et al.  Recognition- and Reactivity-Based Fluorescent Probes for Studying Transition Metal Signaling in Living Systems , 2015, Accounts of chemical research.

[67]  Allegra T. Aron,et al.  Synthetic fluorescent probes for studying copper in biological systems. , 2015, Chemical Society reviews.

[68]  A. Haug,et al.  Role of 64CuCl2 PET/CT in staging of prostate cancer , 2015, Annals of Nuclear Medicine.

[69]  P. Gandhi,et al.  Serum Levels of Metal Ions in Female Patients With Breast Cancer , 2015 .

[70]  Christopher J. Chang,et al.  Subcellular metal imaging identifies dynamic sites of Cu accumulation in Chlamydomonas. , 2015, Nature chemical biology.

[71]  G. M. Oyeyemi,et al.  Trace elements; copper, zinc and selenium, in breast cancer afflicted female patients in LAUTECH Osogbo, Nigeria. , 2015, Indian journal of cancer.

[72]  Haiyan Jing,et al.  Analysis of serum levels of 15 trace elements in breast cancer patients in Shandong, China , 2015, Environmental Science and Pollution Research.

[73]  Allegra T. Aron,et al.  Copper is an endogenous modulator of neural circuit spontaneous activity , 2014, Proceedings of the National Academy of Sciences.

[74]  F. Tuna,et al.  On the interaction of copper(II) with disulfiram. , 2014, Chemical communications.

[75]  J. Kang,et al.  Detection of Increased 64Cu Uptake by Human Copper Transporter 1 Gene Overexpression Using PET with 64CuCl2 in Human Breast Cancer Xenograft Model , 2014, The Journal of Nuclear Medicine.

[76]  Andrea Ballabio,et al.  Wilson Disease Protein ATP7B Utilizes Lysosomal Exocytosis to Maintain Copper Homeostasis , 2014, Developmental cell.

[77]  M. Giorgetti,et al.  In vitro and in vivo anticancer activity of copper(I) complexes with homoscorpionate tridentate tris(pyrazolyl)borate and auxiliary monodentate phosphine ligands. , 2014, Journal of medicinal chemistry.

[78]  J. Prohaska,et al.  Impact of copper deficiency in humans , 2014, Annals of the New York Academy of Sciences.

[79]  Zhen Cheng,et al.  Theranostics of Malignant Melanoma with 64CuCl2 , 2014, The Journal of Nuclear Medicine.

[80]  S. Knapp,et al.  Copper is required for oncogenic BRAF signaling and tumorigenesis , 2013, Nature.

[81]  O. Muzik,et al.  Reduced 64Cu Uptake and Tumor Growth Inhibition by Knockdown of Human Copper Transporter 1 in Xenograft Mouse Model of Prostate Cancer , 2014, The Journal of Nuclear Medicine.

[82]  Matthew E. Welsch,et al.  Regulation of Ferroptotic Cancer Cell Death by GPX4 , 2014, Cell.

[83]  V. Gandin,et al.  Advances in copper complexes as anticancer agents. , 2014, Chemical reviews.

[84]  Andrea Glasauer,et al.  Targeting SOD1 reduces experimental non–small-cell lung cancer. , 2014, The Journal of clinical investigation.

[85]  D. Hanahan,et al.  Bioavailable copper modulates oxidative phosphorylation and growth of tumors , 2013, Proceedings of the National Academy of Sciences.

[86]  A. Armesilla,et al.  Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells , 2013, British Journal of Cancer.

[87]  B. Hasinoff,et al.  Molecular mechanisms of the biological activity of the anticancer drug elesclomol and its complexes with Cu(II), Ni(II) and Pt(II). , 2013, Journal of inorganic biochemistry.

[88]  T. Singh,et al.  Heavy and Trace Metals in Carcinoma of the Gallbladder , 2013, World Journal of Surgery.

[89]  L. Rimsza,et al.  The copper chelator ATN-224 induces peroxynitrite-dependent cell death in hematological malignancies. , 2013, Free radical biology & medicine.

[90]  A. Kjær,et al.  High tumor uptake of (64)Cu: implications for molecular imaging of tumor characteristics with copper-based PET tracers. , 2013, Nuclear medicine and biology.

[91]  J. Gitlin,et al.  Maternofetal and neonatal copper requirements revealed by enterocyte-specific deletion of the Menkes disease protein. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[92]  O. Muzik,et al.  Urinary Copper Elevation in a Mouse Model of Wilson's Disease Is a Regulated Process to Specifically Decrease the Hepatic Copper Load , 2012, PloS one.

[93]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[94]  R. Blackman,et al.  The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells. , 2012, Free radical biology & medicine.

[95]  F. Marincola,et al.  The role of BRAF V600 mutation in melanoma , 2012, Journal of Translational Medicine.

[96]  S. Lutsenko,et al.  Evolution of Copper Transporting ATPases in Eukaryotic Organisms , 2012, Current genomics.

[97]  D. Thiele,et al.  A Novel Role for Copper in Ras/Mitogen-Activated Protein Kinase Signaling , 2012, Molecular and Cellular Biology.

[98]  T. Hirayama,et al.  Near-infrared fluorescent sensor for in vivo copper imaging in a murine Wilson disease model , 2012, Proceedings of the National Academy of Sciences.

[99]  P. Zeng,et al.  Serum total oxidant/antioxidant status and trace element levels in breast cancer patients , 2012, International Journal of Clinical Oncology.

[100]  S. Rodríguez-Enríquez,et al.  Copper compound induces autophagy and apoptosis of glioma cells by reactive oxygen species and jnk activation , 2012, BMC Cancer.

[101]  M. E. Bravo-Gómez,et al.  Genotoxicity of the copper antineoplastic coordination complexes casiopeinas. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[102]  H. Mcardle,et al.  Iron and copper in fetal development. , 2011, Seminars in cell & developmental biology.

[103]  Yongtang Jin,et al.  Combined effects of serum trace metals and polymorphisms of CYP1A1 or GSTM1 on non-small cell lung cancer: a hospital based case-control study in China. , 2011, Cancer epidemiology.

[104]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[105]  Karen Gelmon,et al.  Metastatic behavior of breast cancer subtypes. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[106]  D. Hanahan,et al.  Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator. , 2010, Cancer cell.

[107]  S. Merajver,et al.  Antiangiogenic Tetrathiomolybdate Protects against Her2/neu-Induced Breast Carcinoma by Hypoplastic Remodeling of the Mammary Gland , 2009, Clinical Cancer Research.

[108]  S. O’Day,et al.  Phase II, randomized, controlled, double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage IV metastatic melanoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[109]  Peng Huang,et al.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? , 2009, Nature Reviews Drug Discovery.

[110]  L. Hooper,et al.  Methods of assessment of copper status in humans: a systematic review. , 2009, The American journal of clinical nutrition.

[111]  X. Mao,et al.  The toxicology of Clioquinol. , 2008, Toxicology letters.

[112]  Q. Dou,et al.  Ni(II), Cu(II), and Zn(II) diethyldithiocarbamate complexes show various activities against the proteasome in breast cancer cells. , 2008, Journal of medicinal chemistry.

[113]  J. Bertin,et al.  Elesclomol induces cancer cell apoptosis through oxidative stress , 2008, Molecular Cancer Therapeutics.

[114]  Dylan W Domaille,et al.  Metals in neurobiology: probing their chemistry and biology with molecular imaging. , 2008, Chemical reviews.

[115]  M. Ushio-Fukai,et al.  Novel Role of Antioxidant-1 (Atox1) as a Copper-dependent Transcription Factor Involved in Cell Proliferation* , 2008, Journal of Biological Chemistry.

[116]  D. Thiele,et al.  Assembling the pieces. , 2008, Nature chemical biology.

[117]  G. Wondrak,et al.  Experimental therapeutics: targeting the redox Achilles heel of cancer. , 2007, Current opinion in investigational drugs.

[118]  J. Hwang,et al.  Copper activates TrkB in cortical neurons in a metalloproteinase‐dependent manner , 2007, Journal of neuroscience research.

[119]  F. Meyskens,et al.  UC Irvine UC Irvine Previously Published Works Title Reactive oxygen species : a breath of life or death ? , 2007 .

[120]  M. Yaman,et al.  Distribution of trace metal concentrations in paired cancerous and non-cancerous human stomach tissues. , 2007, World journal of gastroenterology.

[121]  A. Berkenblit,et al.  Phase I Clinical Trial of STA-4783 in Combination with Paclitaxel in Patients with Refractory Solid Tumors , 2007, Clinical Cancer Research.

[122]  Dar-Ren Chen,et al.  Serum and tissue trace elements in patients with breast cancer in Taiwan , 2002, Biological Trace Element Research.

[123]  T. Mitsudomi,et al.  Efficiency of serum copper/zinc ratio for differential diagnosis of patients with and without lung cancer , 1994, Biological Trace Element Research.

[124]  M. Iskra,et al.  Analysis of serum copper and zinc concentrations in cancer patients , 2007, Biological Trace Element Research.

[125]  Q Ping Dou,et al.  Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. , 2006, Cancer research.

[126]  F. Karjodkar,et al.  Circulating Immune Complexes and trace elements (Copper, Iron and Selenium) as markers in oral precancer and cancer : a randomised, controlled clinical trial , 2006, Head & face medicine.

[127]  O. Muzik,et al.  PET of human prostate cancer xenografts in mice with increased uptake of 64CuCl2. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[128]  P. Schumacker,et al.  Reactive oxygen species in cancer cells: live by the sword, die by the sword. , 2006, Cancer cell.

[129]  D. Shaw,et al.  Copper Binding by Tetrathiomolybdate Attenuates Angiogenesis and Tumor Cell Proliferation through the Inhibition of Superoxide Dismutase 1 , 2006, Clinical Cancer Research.

[130]  M. Fleming,et al.  The Steap proteins are metalloreductases. , 2006, Blood.

[131]  M. Gehrmann.  Drug evaluation: STA-4783--enhancing taxane efficacy by induction of Hsp70. , 2006, Current opinion in investigational drugs.

[132]  Jiuhong Kang,et al.  Copper induces histone hypoacetylation through directly inhibiting histone acetyltransferase activity. , 2004, Chemico-biological interactions.

[133]  V. Bhat,et al.  Copper and ceruloplasmin status in serum of prostate and colon cancer patients. , 2003, Indian journal of physiology and pharmacology.

[134]  S. Merajver,et al.  Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. , 2002, Cancer research.

[135]  D. Thiele,et al.  Biochemical Characterization of the Human Copper Transporter Ctr1* , 2002, The Journal of Biological Chemistry.

[136]  M. Harada,et al.  Wilson disease , 2002, Medical Electron Microscopy.

[137]  J. Prohaska,et al.  Copper Transport and Metabolism Are Normal in Aceruloplasminemic Mice* , 2001, The Journal of Biological Chemistry.

[138]  R. Vonk,et al.  Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for biliary copper excretion. , 2000, Gastroenterology.

[139]  T. O’Halloran,et al.  Structure and chemistry of the copper chaperone proteins. , 2000, Current opinion in chemical biology.

[140]  L. Victoriano.  The reactivity of metal species towards thiuram sulfides: an alternative route to the syntheses of metal dithiocarbamates , 2000 .

[141]  S. Merajver,et al.  Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[142]  E. Solomon,et al.  Multicopper Oxidases and Oxygenases. , 1996, Chemical reviews.

[143]  J. Chayen.  Principles of bioinorganic chemistry , 1995 .

[144]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[145]  A. Aisen,et al.  Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients. , 1994, Archives of neurology.

[146]  J. Turnlund,et al.  Copper absorption and retention in young men at three levels of dietary copper by use of the stable isotope 65Cu. , 1989, The American journal of clinical nutrition.

[147]  J. Balibrea,et al.  Use of the copper/zinc ratio in the diagnosis of lung cancer , 1989, Cancer.

[148]  R. Palmer,et al.  Characterization and quantification of copper sulfate-induced vascularization of the rabbit cornea. , 1988, The American journal of pathology.

[149]  B. Halliwell,et al.  Oxygen toxicity, oxygen radicals, transition metals and disease. , 1984, The Biochemical journal.

[150]  J. Schenker,et al.  Copper and Zinc levels in normal and malignant tissues , 1983, Cancer.

[151]  J. Walshe.  TREATMENT OF WILSON'S DISEASE WITH TRIENTINE (TRIETHYLENE TETRAMINE) DIHYDROCHLORIDE , 1982, The Lancet.

[152]  F. Sunderman.  Efficacy of sodium diethyldithiocarbamate (dithiocarb) in acute nickel carbonyl poisoning. , 1979, Annals of clinical and laboratory science.

[153]  L. Wattenberg.  Inhibition of dimethylhydrazine-induced neoplasia of the large intestine by disulfiram. , 1975, Journal of the National Cancer Institute.

[154]  J. Walshe.  Penicillamine, a new oral therapy for Wilson's disease. , 1956, The American journal of medicine.

[155]  H. W. Smith,et al.  Preliminary report on clinical trials of antabuse. , 1949, Canadian Medical Association journal.